LOW-GRADE NMIBC

Clinical trials for LOW-GRADE NMIBC explained in plain language.

Never miss a new study

Get alerted when new LOW-GRADE NMIBC trials appear

Sign up with your email to follow new studies for LOW-GRADE NMIBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Targeted pill trial aims to wipe out early bladder tumors

Disease control Recruiting now

This study is testing an oral medication called TYRA-300 for adults with early-stage, non-muscle-invasive bladder cancer that has a specific genetic change (FGFR3). The goal is to see if the pill can completely eliminate visible tumors left in the bladder after a biopsy. Research…

Matched conditions: LOW-GRADE NMIBC

Phase: PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control

Last updated Mar 09, 2026 14:24 UTC

LOW-GRADE NMIBC

Get alerted when new LOW-GRADE NMIBC trials appear

Targeted pill trial aims to wipe out early bladder tumors